Inhibikase Therapeutics Inc
Company Profile
Business description
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease (“PD”), Parkinson’s-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson’s disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
Contact
3350 Riverwood Parkway SE
Suite 1900
Atlanta GA 30339
USAT: +1 678 392-3419
E: info@inhibikase.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
9
Stocks News & Analysis
stocks
2 ASX shares to avoid
stocks
Is this ASX miner a bargain after shares plunge?
stocks
An undervalued wide moat US share with momentum
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,205.50 | 3.10 | -0.04% |
| CAC 40 | 7,517.49 | 81.14 | -1.07% |
| DAX 40 | 18,394.97 | 162.73 | -0.88% |
| Dow JONES (US) | 40,016.01 | 342.08 | -0.85% |
| FTSE 100 | 8,149.11 | 18.26 | -0.22% |
| HKSE | 17,311.05 | 158.31 | -0.91% |
| NASDAQ | 17,631.97 | 365.38 | -2.03% |
| Nikkei 225 | 39,154.85 | 439.54 | -1.11% |
| NZX 50 Index | 12,530.99 | 105.41 | 0.85% |
| S&P 500 | 5,480.91 | 74.83 | -1.35% |
| S&P/ASX 200 | 7,963.70 | 7.40 | -0.09% |
| SSE Composite Index | 2,901.95 | 13.42 | -0.46% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Argosy Minerals Ltd AGY | 0.05 | 0.03 | -39.51% |
| Pilbara Minerals Ltd PLS | 2.89 | 0.00 | 0.00% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.03% |
| Droneshield Ltd DRO | 1.48 | 0.06 | 3.87% |
| Imugene Ltd IMU | 0.06 | 0.00 | -6.67% |
| Core Lithium Ltd CXO | 0.09 | 0.00 | -4.08% |
| South32 Ltd S32 | 2.96 | 0.02 | -0.67% |
| Zip Co Ltd ZIP | 1.83 | 0.03 | 1.39% |
| Red 5 Ltd RED | 0.42 | 0.03 | 6.41% |
| Worley Ltd WOR | 15.23 | 0.04 | 0.26% |